Navigating Liver Disease in Obesity

This chapter explores the intricate relationship between obesity and liver disease progression, particularly focusing on metabolic dysfunction associated with steatohepatitis. It highlights the significance of the ESSENCE trial, revealing promising findings on GLP-1 medications and their effectiveness in treating liver health. Additionally, the discussion addresses ethical considerations in clinical trials and the implications of trial design on patient welfare and outcomes.